Kim Kline to Drug Synergism
This is a "connection" page, showing publications Kim Kline has written about Drug Synergism.
Connection Strength
0.231
-
Tiwary R, Yu W, Sanders BG, Kline K. a-TEA cooperates with MEK or mTOR inhibitors to induce apoptosis via targeting IRS/PI3K pathways. Br J Cancer. 2011 Jan 04; 104(1):101-9.
Score: 0.091
-
Snyder RM, Yu W, Jia L, Sanders BG, Kline K. Vitamin E analog alpha-TEA, methylseleninic acid, and trans-resveratrol in combination synergistically inhibit human breast cancer cell growth. Nutr Cancer. 2008; 60(3):401-11.
Score: 0.074
-
Yu W, Heim K, Qian M, Simmons-Menchaca M, Sanders BG, Kline K. Evidence for role of transforming growth factor-beta in RRR-alpha-tocopheryl succinate-induced apoptosis of human MDA-MB-435 breast cancer cells. Nutr Cancer. 1997; 27(3):267-78.
Score: 0.035
-
Charpentier A, Simmons-Menchaca M, Yu W, Zhao B, Qian M, Heim K, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate enhances TGF-beta 1, -beta 2, and -beta 3 and TGF-beta R-II expression by human MDA-MB-435 breast cancer cells. Nutr Cancer. 1996; 26(2):237-50.
Score: 0.032